- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ONC's Steven Posnack on Improving Interoperability
There are a couple of areas where interoperability can still be improved, which requires work from both the private and the public sector, said Steven Posnack, MS, MHS, director of the Office of Standards and Technology at the Office of the National Coordinator for Health Information Technology.
There are a couple of areas where interoperability can still be improved, which requires work from both the private and the public sector, said Steven Posnack, MS, MHS, director of the Office of Standards and Technology at the Office of the National Coordinator for Health Information Technology, at the US News Hospital of Tomorrow conference.
However, once these technologies are interoperable, there are a multitude of benefits, and likely more which ONC hasn’t even thought of yet, he added.
“There are a lot of different benefits, ranging first and foremost to clinicians having the data available for the right patient at the right time to provide the right care.” Mr Posnack said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
